Detalhe da pesquisa
1.
Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
BJU Int
; 110(5): 699-708, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22313585